Cognitive Impairment in Adults with Non−Central Nervous System Cancers (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (11/05/2018)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information About Cognitive Impairment in Cancer Survivors

Added text to state that one study of 226 participants demonstrated that breast cancer patients experienced overall cognitive decline and scored consistently worse on cognitive tests, which was mediated by post-traumatic stress disorder (PTSD), indicating that PTSD may contribute in part to cognitive decline (cited Hermelink et al. as reference 8).

Research Studies on Prevalence, Risk Factors, and the Natural History of Cognitive Impairment

Added Objective cognitive deficits in breast cancer survivors receiving endocrine therapy as a new subsection.

This summary is written and maintained by the PDQ Supportive and Palliative Care Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Interventions for Cognitive Impairment

Next section >
About This PDQ Summary

Cognitive Impairment in Adults with Non-CNS Cancers (PDQ®)—Health Professional Version - National Cancer Institute